Cell-based Product Formulation

Cell-Based Product Formulation is a sterile product development approach within biopharmaceutical manufacturing that specifically involves the integration, maintenance, and delivery of viable living cells as active therapeutic components, distinguished from other sterile formulations by its reliance on cellular viability, functionality, and aseptic handling throughout the formulation process.

22

Publications

893

Citations

111

Authors

63

Institutions

Publications per year

2017–2026

8

Authors

111

  1. KC
    Kurt C. Gunter

    National Institutes of Health, United States

    2 publications · 99 citations

    2

    h-index

  2. DI
    Dimitrios I. Gerogiorgis

    University of Edinburgh, United Kingdom

    1 publications · 30 citations

    1

    h-index

  3. PS
    Paula Salmikangas

    University of Helsinki, Finland

    1 publications · 11 citations

    1

    h-index

  4. HS
    Hirokazu Sugiyama

    The University of Tokyo, Japan

    1 publications · 30 citations

    1

    h-index

  5. YG
    Yann Godfrin

    Erytech Pharma (France), France

    1 publications · 87 citations

    1

    h-index

1–5 of 111

Venues

  1. Journal of Pharmaceutical Sciences

    2 publications · 40 citations

    2

    h-index

  2. Journal of Translational Medicine

    JTM · 2 publications · 66 citations

    2

    h-index

  3. PubMed

    Repository · 2 publications · 33 citations

    2

    h-index

  4. Biologicals

    1 publications · 25 citations

    1

    h-index

  5. Bone

    1 publications · 28 citations

    1

    h-index

1–5